Phase III Trials Of Covid Drug Movfor Show Positive Results, Says Hetero
Drug firm Hetero on Saturday announced positive results of Phase III trials of Movfor (Molnupiravir), an investigational oral antiviral COVID-19 … Continue reading Phase III Trials Of Covid Drug Movfor Show Positive Results, Says Hetero
